Bookmark and Share

5 Cash-Hoarding Stocks With Top Yields And Strong Cash Flows (PFE, COP, CVX, LLY, MRK)

While I made my daily research on several stock market screeners, one question came deeply into my mind. When the markets are so expensive, who are the cheapest stocks, not by P/E but in terms of cash flow or Ebitda. I also included the Cash and debt of the company.

So, the good thing is that you can buy stocks in every market cycle but you must be careful with your investment spending.

Your final return depends in the end on your inital investment cost and if you buy at a high price, your return will fall into a low or negative area.

Good to know that dividends can upper your yield but my experience is that it could be very painful for an investor to look at a suffering return over years.

These are my criteria:
- Market Cap over 15 Billion
- Dividend Yield in the higher yield space over 3 percent
- Cheapest Enterprise-To-Ebitda Ratio on the market

My screen delivered some interesting results in the large cap area: Oil companies are top. 

COP, CVX are the best results in terms of EV/EBITDA. Both have a ratio of around 5 which is very comfortable in the current situation but what about Russia and the Middle East crises?

My second best results came from the technology space: Intel and Verizon. Warren Buffett added his VZ stake by one third on the past quarter and he might be right because VZ is much cheaper than rival AT&T. The EV/EBITDA ratio is only at 6.35 while T has a ratio of 9.66.

Healthcare is also good positioned with Merck, Pfizer and Eli Lilly but those are suffering on the patent cliff.




I believe that it does not make sense to look at stocks with a higher ratio. For sure cash flows can come down and the full sheet becomes trash but most of the companies serve values. What are your thoughts about my current screen? How are you invested?

These are the best results in terms of lowest debt-to-equity ratio:


ConocoPhillips (NYSE:COP) has a market capitalization of $98.66 billion. The company employs 19,200 people, generates revenue of $56.185 billion and has a net income of $8.037 billion. ConocoPhillips’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $20.761 billion. The EBITDA margin is 36.95 percent (the operating margin is 22.78 percent and the net profit margin 14.30 percent).

Financial Analysis: The total debt represents 18.35 percent of ConocoPhillips’s assets and the total debt in relation to the equity amounts to 41.59 percent. Due to the financial situation, a return on equity of 15.94 percent was realized by ConocoPhillips. Twelve trailing months earnings per share reached a value of $6.49. Last fiscal year, ConocoPhillips paid $2.70 in the form of dividends to shareholders.


Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.36, the P/S ratio is 1.77 and the P/B ratio is finally 1.91. The dividend yield amounts to 3.61 percent and the beta ratio has a value of 1.01.



Long-Term Stock Price Chart Of ConocoPhillips (COP)
Long-Term Dividend Payment History of ConocoPhillips (COP)
Long-Term Dividend Yield History of ConocoPhillips (COP)


If you would like to receive more dividend stock ideas, you should subscribe to my free e-mail list. Alternatively, you can follow me on Facebook or Twitter.

Pfizer (NYSE:PFE) has a market capitalization of $183.38 billion. The company employs 77,700 people, generates revenue of $51.584 billion and has a net income of $11.410 billion. Pfizer’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $23.623 billion. The EBITDA margin is 45.80 percent (the operating margin is 31.32 percent and the net profit margin 22.12 percent).


Financial Analysis: The total debt represents 21.20 percent of Pfizer’s assets and the total debt in relation to the equity amounts to 47.82 percent. Due to the financial situation, a return on equity of 14.45 percent was realized by Pfizer. Twelve trailing months earnings per share reached a value of $1.59. Last fiscal year, Pfizer paid $0.96 in the form of dividends to shareholders.


Market Valuation: Here are the price ratios of the company: The P/E ratio is 18.24, the P/S ratio is 3.54 and the P/B ratio is finally 2.42. The dividend yield amounts to 3.61 percent and the beta ratio has a value of 0.68.



Long-Term Stock Price Chart Of Pfizer (PFE)
Long-Term Dividend Payment History of Pfizer (PFE)
Long-Term Dividend Yield History of Pfizer (PFE)

Chevron (NYSE:CVX) has a market capitalization of $241.37 billion. The company employs 64,600 people, generates revenue of $220.264 billion and has a net income of $21.597 billion. Chevron’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $41.912 billion. The EBITDA margin is 19.03 percent (the operating margin is 12.59 percent and the net profit margin 9.81 percent).


Financial Analysis: The total debt represents 8.05 percent of Chevron’s assets and the total debt in relation to the equity amounts to 13.70 percent. Due to the financial situation, a return on equity of 15.00 percent was realized by Chevron. Twelve trailing months earnings per share reached a value of $10.48. Last fiscal year, Chevron paid $3.90 in the form of dividends to shareholders.


Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.13, the P/S ratio is 1.10 and the P/B ratio is finally 1.64. The dividend yield amounts to 3.35 percent and the beta ratio has a value of 1.08.



Long-Term Stock Price Chart Of Chevron (CVX)
Long-Term Dividend Payment History of Chevron (CVX)
Long-Term Dividend Yield History of Chevron (CVX)


If you would like to receive more dividend stock ideas, you should subscribe to my free e-mail list. Alternatively, you can follow me on Facebook or Twitter.

Merck (NYSE:MRK) has a market capitalization of $170.68 billion. The company employs 76,000 people, generates revenue of $44.033 billion and has a net income of $4.517 billion. Merck’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $23.222 billion. The EBITDA margin is 52.74 percent (the operating margin is 13.53 percent and the net profit margin 10.26 percent).

Financial Analysis: The total debt represents 23.72 percent of Merck’s assets and the total debt in relation to the equity amounts to 50.36 percent. Due to the financial situation, a return on equity of 8.57 percent was realized by Merck. Twelve trailing months earnings per share reached a value of $1.90. Last fiscal year, Merck paid $1.72 in the form of dividends to shareholders.


Market Valuation: Here are the price ratios of the company: The P/E ratio is 31.19, the P/S ratio is 3.86 and the P/B ratio is finally 3.46. The dividend yield amounts to 2.99 percent and the beta ratio has a value of 0.40.



Long-Term Stock Price Chart Of Merck (MRK)
Long-Term Dividend Payment History of Merck (MRK)
Long-Term Dividend Yield History of Merck (MRK)

Eli Lilly (NYSE:LLY) has a market capitalization of $69.63 billion. The company employs 39,235 people, generates revenue of $23.113 billion and has a net income of $4.684 billion. Eli Lilly’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6.877 billion. The EBITDA margin is 29.76 percent (the operating margin is 23.24 percent and the net profit margin 20.27 percent).

Financial Analysis: The total debt represents 14.79 percent of Eli Lilly’s assets and the total debt in relation to the equity amounts to 29.57 percent. Due to the financial situation, a return on equity of 28.92 percent was realized by Eli Lilly. Twelve trailing months earnings per share reached a value of $3.14. Last fiscal year, Eli Lilly paid $1.96 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 19.83, the P/S ratio is 3.00 and the P/B ratio is finally 3.93. The dividend yield amounts to 3.16 percent and the beta ratio has a value of 0.45.


Long-Term Stock Price Chart Of Eli Lilly (LLY)
Long-Term Dividend Payment History of Eli Lilly (LLY)
Long-Term Dividend Yield History of Eli Lilly (LLY)


1-Year Performance (Click to enlarge)

Screener Results (Click to enlarge)


Do you like this article? If yes, please support us and hit the button for a Facebook Like, make a tweet or post a comment in the Dividend Yield community! Thank you so much, we really appreciate it.

------------

Related Stock Ticker Symbols:
PFE, COP, CVX, LLY, MRK

*I am long INTC, . I receive no compensation to write about these specific stocks, sector or theme. I don't plan to increase or decrease positions or obligations within the next 72 hours.

For the other stocks: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.


No comments:

Post a Comment

Do you have any questions or notes to this article?
Please let me know your thoughts and we will discuss it.